RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Results of Operations and Financial Condition

RTI SURGICAL, INC. (NASDAQ:RTIX) Files An 8-K Results of Operations and Financial Condition
Item 2.02.

Story continues below

RTI SURGICAL, INC. Exhibit
EX-99.1 2 d714049dex991.htm EX-99.1 EX-99.1 Exhibit 99.1   Press Release RTI Surgical® Announces Fourth Quarter and Full Year 2018 Results Results in Line with Guidance Driven by Operational Excellence Initiatives and Growth in Spine and OEM Franchises ALACHUA,…
To view the full exhibit click here

About RTI SURGICAL, INC. (NASDAQ:RTIX)

RTI Surgical, Inc. is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties. It processes donated human musculoskeletal and other tissue, including bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine and porcine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE, TUTOPLAST and CANCELLE SP sterilization processes, and manufactures metal and synthetic implants for distribution to hospitals and surgeons. The Company distributes its implants and services in approximately 50 states and in over 45 countries across the world.

An ad to help with our costs